Enterome enters into a microbiome-based development collaboration with AbbVie in Crohn’s disease
Paris, France – 12 November 2014
Enterome enters into a microbiome-based development collaboration with AbbVie in Crohn’s disease.
Collaboration to generate novel diagnostic products to support personalized therapies for microbiome-related diseases